Radiopharm Theranostics Ltd (RAD) — Financial Flexibility Index

Latest as of December 2025: -0.55x

Radiopharm Theranostics Ltd (RAD) has a Financial Flexibility Index of -0.55x as of December 2025. Free cash flow of AU$-22.67 Million (operating CF AU$-22.67 Million minus capex AU$4.00) represents -1% of total liabilities (AU$41.23 Million). Check Radiopharm Theranostics Ltd (RAD) strategic asset index to assess the company's strategic physical and investment asset allocation.

Financial Flexibility Index

-0.55x
Free Cash Flow / Total Liabilities

Free Cash Flow

AU$-22.67 Million
Operating CF − Capex

Total Liabilities

AU$41.23 Million
AUD

Capital Expenditures

AU$4.00
AUD

Radiopharm Theranostics Ltd Financial Flexibility Index (2021–2025)

Historical Financial Flexibility Index trend for Radiopharm Theranostics Ltd across 5 annual periods. See RAD working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Annual Financial Flexibility Index for Radiopharm Theranostics Ltd (2021–2025)

Year-by-year free cash flow to debt coverage for Radiopharm Theranostics Ltd. For the full company profile including market capitalisation, see market cap of Radiopharm Theranostics Ltd.

Year Flexibility Index Free Cash Flow (AUD) Operating CF Total Liabilities YoY Change
2025 -0.84x AU$-36.65 Million AU$-36.65 Million AU$43.61 Million ▼ -63.4%
2024 -0.51x AU$-22.98 Million AU$-22.98 Million AU$44.68 Million ▲ +30.3%
2023 -0.74x AU$-21.67 Million AU$-23.20 Million AU$29.37 Million ▼ -181.7%
2022 0.90x AU$18.43 Million AU$-9.91 Million AU$20.42 Million ▲ +573.3%
2021 -0.19x AU$-30.16K AU$-32.91K AU$158.14K
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities